US Patent

US9616180 — Automatic injection device with a top release mechanism

Formulation · Assigned to Novo Nordisk AS · Expires 2026-01-20 · 0y expired

Vulnerability score 36/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a handheld mechanical injection device that automatically injects set doses of a liquid medicament, such as Ozempic, from a medical reservoir.

USPTO Abstract

The present invention relates to a handheld mechanical injection device by which set doses of a liquid medicament can be injected from a medical reservoir. The medicament is expelled through an injection needle by release of a power reservoir in the device, the power reservoir being fully or partially released by actuation of a user operable release member being positioned at or near an upper end of the injection device, the upper end being that end of the injection device which is opposite the injection needle.

Drugs covered by this patent

Patent Metadata

Patent number
US9616180
Jurisdiction
US
Classification
Formulation
Expires
2026-01-20
Drug substance claim
No
Drug product claim
Yes
Assignee
Novo Nordisk AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.